维普中文期刊产品整合服务
50篇 您的检索式:作者名="MITLAK BH"
    题名 作者 年代 出处 被引量
1Intermittent administration of bovine PTH-( 1-34 ) increases serum 1,25-dihydroxyvitamin D concenrations and spinal bone density in senile (23 month)rats显示文摘Mitlak BH Williams DC Bryant HU 1992J Bone Miner Res1992,7,5:1
2Effects of raloxifene on bone mineral density,serum cholesterol concentrations,and uterine endometrium in postmenopausal women显示文摘Delmas PD Bjarnason NH Mitlak BH 0,,7:1
3Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women显示文摘Delmas PD Bjarnason NH Mitlak BH 1997N Engl J Med1997,337,23:1
4Diagnosis and treatment of osteoporosis显示文摘Mitlak BH Nussbaum SR 1993Annu Rev Med1993,44,:1
5Selective estrogen receptor modulators显示文摘 Cohen FJ 1999Drugs1999,57,:1
6Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis显示文摘Neer RM Arnaud CD Zanchetta JR Prince R Gaich GA Reginster JY Hodsman AB Eriksen EF Ish-Shalom S Genant HK Wang O Mitlak BH 0,,:1
7Long-term raloxifene for postmenopausal osteoporosis显示文摘Recker RR Mitlak BH Ni X 2011Curt Med Res Opin2011,27,9:1
8Sustained vertebral fracture risk reduction after withdrawal of teriparatide in post-menopausal women with osteoporosis显示文摘Lindsay R Scheele WH Neer R Pohl G Adami S Mautalen C Reginster JY Stepan JJ Myers SL Mitlak BH 0,,:1
9显示文摘Delmas PD Bjarnason NH Mitlak BH 1997N Engl J Med1997,337,:1
10Effects of raloxifene on bone mineral density,serum cholesterol concentrations,and uterine endometrium in postmenopausal women显示文摘Delmas PD Bjarnason NH Mitlak BH 1997N Engl J Med1997,337,:1
11Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene:results from a 3-year randomized clinical trial显示文摘Ettinger B Black DM Mitlak BH 1999JAMA1999,282,:1
12Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis显示文摘Neer RM Arnaud CD Zanchetta JR Prince R Gaich GA Reginster JY Hodsman AB Eriksen EF Ish-Shalom S Genant HK Wang O Mitlak BH N Engl J Me0,,:1
13Effects of raloxifene on bone mineral density, serum cholesterol concentration, and uterine endometrium in postmenopausal women 显示文摘DELMAS PD BJARNASON NH MITLAK BH 1997New Engl J Med1997,337,:1
14Effects of raloxifene on bone mineral density,serum cholesterol concentrations,and uterine endometrium in postmenopausal women显示文摘Delmas PD Bjarnason NH Mitlak BH Ravoux AC Shah AS Huster WJ 1997New Engl J Med1997,337,:1
15Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene 显示文摘Ettinger B Black DM Mitlak BH 1999JAMA1999,282,7:1
16Reduction of vertebral fracture risk in postmenopansal women with osteoporosis treated with raloxifence results from a years randomized clinical trail显示文摘Ettingre B Black DM Mitlak BH 1999JAMA1999,282,7:1
17Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial显示文摘ETTINGER B BLACK DM MITLAK BH 1999JMedAmAssoc1999,282,7:1
18Selective estrogen receptor modulators:A look ahead显示文摘 Cohen FJ 1999Drugs1999,57,4:1
19Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and u- terine endometrium in postmenopausal women显示文摘Delmas PD Bjamason NH Mitlak BH 1997N Engl J Med1997,337,:1
20Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometfium in postmenopausal women 显示文摘Delmas PD Bjarnason NH Mitlak BH 1997N Engl J Med1997,337,23:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费